Bregua Corp

Insider Reports History

Entity
Company
Location
C/O Janux Therapeutics, Inc., 11099 N. Torrey Pines Road, Suite 290, La Jolla, CA
Signature
/s/ Klaus Dorner, Director of Bregua Corporation
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bregua Corp:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. 10%+ Owner Common Stock 3.75M $22M $5.87 Jun 15, 2021 Direct
Janux Therapeutics, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 Jun 15, 2021 Direct
Janux Therapeutics, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 Jun 15, 2021 Direct
Janux Therapeutics, Inc. 10%+ Owner Series Seed 2 Convertible Preferred Stock 0 Jun 15, 2021 Direct
Janux Therapeutics, Inc. 10%+ Owner Series Seed Convertible Preferred Stock 0 Jun 15, 2021 Direct

Insider Reports Filed by Bregua Corp

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JANX Janux Therapeutics, Inc. Jun 15, 2021 9 $1M 4 Jun 16, 2021 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 10, 2021 0 $0 3 Jun 10, 2021 10%+ Owner